TG4050

· Transgene

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for TG4050, covering 2025-11-14 to 2026-01-16. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial Evaluating TG4050 in Head and Neck Cancer [Phase 1, Phase 2]